CANDIDA
AURIS – SCIENCE & TECHNOLOGY
News:
Researchers from Singapore General Hospital (SGH), A*STAR's Genome Institute of
Singapore (GIS), and Yong Loo Lin School of Medicine at the National University
of Singapore (NUS Medicine) have discovered a new clade of Candida auris,
raising the total known clades to six.
 - This finding enhances the
     understanding of Candida auris diversity and its public health
     implications.
 
 
What’s
in the news?
Candida Auris
 - Candida auris, often abbreviated as
     C. auris, is a pathogenic fungus that poses a
     significant threat to public health worldwide.
 
 - It was first identified in Japan in
     2009, it has since been found in multiple countries, raising alarms among
     health professionals due to its high transmissibility and resistance to
     multiple antifungal drugs.
 
 - Candida auris is a species of fungus
     known for causing severe infections, particularly in
     hospitalized patients with underlying medical conditions.
 
 - It is highly transmissible and
     challenging to eradicate, making it a critical concern in healthcare
     settings.
 
 - The fungus can survive on surfaces
     for extended periods, facilitating its spread in
     hospitals and nursing homes.
 
 - The mortality rate associated
     with auris infections is estimated to be between 30% and
     60%.
 
Recent
Discoveries
 - A team of researchers from
     Singapore General Hospital, A*STAR's Genome Institute of Singapore, and
     the Yong Loo Lin School of Medicine at the National University of
     Singapore recently identified a new clade (type) of C. auris, bringing the
     total known clades to six.
 
 - This discovery highlights the
     evolving nature of this pathogen and the need for continuous monitoring
     and research.
 
 
Transmissions:
 - Most cases of the fungus Candida
     auris have been reported in healthcare environments,
     such as hospitals and nursing homes.
 
 - It is primarily thought to spread
     through contact with contaminated surfaces or via person-to-person
     transmission.
 
 - Individuals with pre-existing medical
     conditions, recent hospitalizations, or those with invasive devices are at
     a higher risk of contracting this fungus.
 
 
Impacts-
Two ways:
 - Asymptomatic Colonization:
     The fungus may colonize specific areas such as the skin, rectum, or mouth
     without causing any symptoms. In this state, individuals can still spread
     the fungus to others.
 
 - Invasive Infections:
     The fungus can penetrate the bloodstream or wounds, leading to severe
     infections.
 
 
Common
Symptoms
 - The symptoms of auris infections
     often resemble those of other common illnesses, making diagnosis
     challenging.
 
 - The most common symptoms include
     persistent fever and chills that do not improve with antibiotic treatment.
 
 
Treatment
 - Most auris infections
     can be treated with antifungal medications known
     as echinocandins. However, some strains have developed resistance to
     standard antifungal treatments, complicating treatment efforts.
 
 - In such cases, a combination of
     multiple antifungals at high doses may be
     necessary to manage the infection effectively.
 
 
Public
Health Implications
 - The recent identification of a sixth
     clade of C. auris necessitates improved
     surveillance capabilities and the development of new methods to augment
     existing strategies.
 
 - Enhanced genomic and metagenomic
     research, combined with collaborative efforts among researchers and
     clinicians, is crucial for effective pandemic preparedness and response.
 
 
Source:
https://medicalxpress.com/news/2024-08-candida-auris-global-health-threat.html